EMAIL THIS PAGE TO A FRIEND

Oncogene

Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.


PMID 24037523

Abstract

Phosphoinositide-dependent kinase-1 (PDK1) is a serine/threonine protein kinase that phosphorylates members of the conserved AGC kinase superfamily, including AKT and protein kinase C (PKC), and is implicated in important cellular processes including survival, metabolism and tumorigenesis. In large cohorts of nevi and melanoma samples, PDK1 expression was significantly higher in primary melanoma, compared with nevi, and was further increased in metastatic melanoma. PDK1 expression suffices for its activity, owing to auto-activation, or elevated phosphorylation by phosphoinositide 3'-OH-kinase (PI3K). Selective inactivation of Pdk1 in the melanocytes of Braf(V600E)::Pten(-/-) or Braf(V600E)::Cdkn2a(-/-)::Pten(-/-) mice delayed the development of pigmented lesions and melanoma induced by systemic or local administration of 4-hydroxytamoxifen. Melanoma invasion and metastasis were significantly reduced or completely prevented by Pdk1 deletion. Administration of the PDK1 inhibitor GSK2334470 (PDKi) effectively delayed melanomagenesis and metastasis in Braf(V600E)::Pten(-/-) mice. Pdk1(-/-) melanomas exhibit a marked decrease in the activity of AKT, P70S6K and PKC. Notably, PDKi was as effective in inhibiting AGC kinases and colony forming efficiency of melanoma with Pten wild-type (WT) genotypes. Gene expression analyses identified Pdk1-dependent changes in FOXO3a-regulated genes, and inhibition of FOXO3a restored proliferation and colony formation of Pdk1(-/-) melanoma cells. Our studies provide direct genetic evidence for the importance of PDK1, in part through FOXO3a-dependent pathway, in melanoma development and progression.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D9320
Anti-PDK1 (286-300) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB2500770
Anti-PDK1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
P3110
Anti-PDK1 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
HPA027376
Anti-PDK1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2103146
Anti-PDK1 antibody produced in rabbit, affinity isolated antibody
SAB4502160
Anti-PDK1 antibody produced in rabbit, affinity isolated antibody
SAB4300290
Anti-PDPK1 (Ab-241) antibody produced in rabbit, affinity isolated antibody
SAB1406242
Anti-PDPK1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV30313
Anti-PDPK1 antibody produced in rabbit, affinity isolated antibody
WH0005163M2
Monoclonal Anti-PDK1 antibody produced in mouse, clone 3E1, purified immunoglobulin, buffered aqueous solution
SAB1404188
Monoclonal Anti-PDK1 antibody produced in mouse, clone 3B7, purified immunoglobulin, buffered aqueous solution
SAB5300405 Monoclonal Anti-PDK1 antibody produced in mouse, clone 4A11, ascites fluid
SAB1402098
Monoclonal Anti-PDPK2 antibody produced in mouse, clone 1G3, purified immunoglobulin, buffered aqueous solution